Valuation: Inogen, Inc.

Market Cap 192M 172M 159M 144M 269M 18.32B 273M 1.9B 757M 9.59B 722M 707M 30.37B P/E 2026 *
-9.48x
P/E 2027 * -15.3x
Enterprise Value 192M 172M 159M 144M 269M 18.32B 273M 1.9B 757M 9.59B 722M 707M 30.37B EV / Sales 2026 *
0.54x
EV / Sales 2027 * 0.52x
Free-Float
87.05%
Yield 2026 *
-
Yield 2027 * -
1 day-0.14%
1 week+2.98%
Current month+37.57%
1 month+35.01%
3 months+12.75%
6 months+3.57%
Current year+7.89%
1 week 6.94
Extreme 6.94
7.34
1 month 5.26
Extreme 5.265
7.34
Current year 5.04
Extreme 5.045
7.67
1 year 5.04
Extreme 5.045
8.55
3 years 4.37
Extreme 4.37
13.33
5 years 4.13
Extreme 4.13
40.49
10 years 4.13
Extreme 4.13
287.79
Manager TitleAgeSince
Chief Executive Officer 55 10/11/2023
Director of Finance/CFO 48 06/04/2026
Chief Tech/Sci/R&D Officer - 29/09/2025
Director TitleAgeSince
Director/Board Member 66 06/08/2014
Chairman 65 29/12/2021
Director/Board Member 59 22/03/2022
Date Insider Type Main position Quantity % Market Cap. Importance
1/9/26 Free

Controller/Auditor

1,500 0.0057%
1/9/26 Free

General Counsel

46,443 0.1750%
1/9/26 Free

Chief Executive Officer

1,500 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
-0.14%+2.98%-13.79%+64.03% 192M
+1.00%+1.08%-16.72%+11.42% 178B
+2.36%+1.38%-15.76%+18.57% 117B
+2.46%+0.45%+5.77%+38.66% 116B
+0.28%+0.59%-44.02%+5.89% 91.03B
+1.16%-3.23%-1.69%+76.66% 61.89B
-0.32%-0.66%+10.51%+81.65% 55.85B
+0.82%-2.06%+8.14%-21.82% 53.16B
+2.02%+1.20%-8.62%+44.69% 44.35B
+1.94%+1.59%-1.11%-6.97% 33.59B
Average +1.17%+1.72%-7.73%+31.28% 75.03B
Weighted average by Cap. +1.38%+1.25%-10.20%+25.48%

Financials

2026 *2027 *
Net sales 356M 319M 295M 267M 498M 33.94B 506M 3.51B 1.4B 17.76B 1.34B 1.31B 56.26B 373M 334M 308M 279M 521M 35.48B 529M 3.67B 1.47B 18.57B 1.4B 1.37B 58.81B
Net income -20.8M -18.63M -17.19M -15.55M -29.08M -1.98B -29.55M -205M -81.81M -1.04B -78.06M -76.4M -3.28B -13.35M -11.96M -11.03M -9.98M -18.67M -1.27B -18.97M -132M -52.51M -665M -50.1M -49.03M -2.11B
Net Debt - -
Projected Income Statement - Annual - Inogen, Inc.
Logo Inogen, Inc.
Inogen, Inc. is a global medical technology company offering respiratory products for use in the homecare setting. The Company partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products available. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators (POCs), used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. It also distributes the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure (CPAP) masks in the United States. Its proprietary Inogen One and Inogen Rove POC systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available.
Employees
753
Date Price Change Volume
30/10/26 USD 7.250 0.00% 73,488
28/10/26 USD 7.250 +1.68% 281,212
27/10/26 USD 7.130 +0.71% 199,611
26/10/26 USD 7.080 -0.28% 191,801
23/10/26 USD 7.100 +0.85% 239,253
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
MarketScreener Ratings - Inogen, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
7.250USD
Average target price
12.00USD
Spread / Average Target
+65.52%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Inogen, Inc.
  1. Stock Market
  2. Stocks
  3. INGN Stock